IMUX
Price
$1.06
Change
+$0.06 (+6.00%)
Updated
Dec 23, 04:59 PM (EDT)
58 days until earnings call
VERV
Price
$5.90
Change
+$0.16 (+2.79%)
Updated
Dec 23, 04:59 PM (EDT)
64 days until earnings call
Ad is loading...

IMUX vs VERV

Header iconIMUX vs VERV Comparison
Open Charts IMUX vs VERVBanner chart's image
Immunic
Price$1.06
Change+$0.06 (+6.00%)
Volume$19.64K
CapitalizationN/A
Verve Therapeutics
Price$5.90
Change+$0.16 (+2.79%)
Volume$39.04K
CapitalizationN/A
IMUX vs VERV Comparison Chart
Loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMUX vs. VERV commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUX is a Hold and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 24, 2024
Stock price -- (IMUX: $1.07 vs. VERV: $5.90)
Brand notoriety: IMUX and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUX: 75% vs. VERV: 79%
Market capitalization -- IMUX: $96.38M vs. VERV: $499.52M
IMUX [@Biotechnology] is valued at $96.38M. VERV’s [@Biotechnology] market capitalization is $499.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUX’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • IMUX’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than IMUX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUX’s TA Score shows that 2 TA indicator(s) are bullish while VERV’s TA Score has 5 bullish TA indicator(s).

  • IMUX’s TA Score: 2 bullish, 8 bearish.
  • VERV’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VERV is a better buy in the short-term than IMUX.

Price Growth

IMUX (@Biotechnology) experienced а -3.60% price change this week, while VERV (@Biotechnology) price change was +9.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.75%. For the same industry, the average monthly price growth was -2.52%, and the average quarterly price growth was +3.67%.

Reported Earning Dates

IMUX is expected to report earnings on Feb 20, 2025.

VERV is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-1.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($500M) has a higher market cap than IMUX($96.4M). IMUX YTD gains are higher at: -28.667 vs. VERV (-57.676). IMUX has higher annual earnings (EBITDA): -95.68M vs. VERV (-219.97M). VERV has more cash in the bank: 540M vs. IMUX (59.1M). IMUX has less debt than VERV: IMUX (899K) vs VERV (71.3M). VERV has higher revenues than IMUX: VERV (24.4M) vs IMUX (0).
IMUXVERVIMUX / VERV
Capitalization96.4M500M19%
EBITDA-95.68M-219.97M43%
Gain YTD-28.667-57.67650%
P/E RatioN/AN/A-
Revenue024.4M-
Total Cash59.1M540M11%
Total Debt899K71.3M1%
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMUXVERV
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 16 days ago
86%
Bullish Trend 1 day ago
87%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 7 days ago
84%
View a ticker or compare two or three
Ad is loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FUNYX35.990.18
+0.50%
Pioneer Fundamental Growth Y
SCAVX14.620.04
+0.27%
AB Small Cap Value A
GSCKX14.25N/A
N/A
Goldman Sachs International Eq Inc C
MSIWX15.32N/A
N/A
Morgan Stanley Inst EMkts Ldrs IR
EMCCX56.54-0.20
-0.35%
Empiric Class C

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with NTLA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
+7.00%
NTLA - IMUX
42%
Loosely correlated
-0.66%
PGEN - IMUX
41%
Loosely correlated
-2.16%
VERV - IMUX
41%
Loosely correlated
+2.79%
CRSP - IMUX
40%
Loosely correlated
-0.59%
DNA - IMUX
39%
Loosely correlated
-6.15%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+2.79%
BEAM - VERV
56%
Loosely correlated
-1.07%
CRSP - VERV
51%
Loosely correlated
-0.59%
NTLA - VERV
49%
Loosely correlated
-0.66%
EDIT - VERV
48%
Loosely correlated
-4.58%
PRME - VERV
48%
Loosely correlated
-3.10%
More